Kamada Ltd. (KMDA)
8.08
+0.30
(+3.92%)
USD |
NASDAQ |
Oct 09, 16:00
8.07
-0.01
(-0.12%)
After-Hours: 20:00
Kamada Enterprise Value : 407.84M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 407.84M |
| October 08, 2026 | 390.24M |
| October 07, 2026 | 396.88M |
| October 06, 2026 | 409.57M |
| October 05, 2026 | 403.22M |
| October 02, 2026 | 421.11M |
| October 01, 2026 | 414.76M |
| September 30, 2026 | 429.76M |
| September 29, 2026 | 443.32M |
| September 28, 2026 | 438.99M |
| September 25, 2026 | 444.76M |
| September 24, 2026 | 451.11M |
| September 23, 2026 | 447.65M |
| September 22, 2026 | 453.42M |
| September 21, 2026 | 445.92M |
| September 18, 2026 | 452.26M |
| September 17, 2026 | 441.88M |
| September 16, 2026 | 414.18M |
| September 15, 2026 | 408.41M |
| September 14, 2026 | 421.11M |
| September 11, 2026 | 398.61M |
| September 10, 2026 | 402.65M |
| September 09, 2026 | 415.34M |
| September 08, 2026 | 419.95M |
| September 04, 2026 | 434.38M |
| Date | Value |
|---|---|
| September 03, 2026 | 418.80M |
| September 02, 2026 | 426.30M |
| September 01, 2026 | 425.15M |
| August 31, 2026 | 416.49M |
| August 28, 2026 | 419.95M |
| August 27, 2026 | 418.22M |
| August 26, 2026 | 425.15M |
| August 25, 2026 | 439.57M |
| August 24, 2026 | 428.03M |
| August 21, 2026 | 417.07M |
| August 20, 2026 | 404.38M |
| August 19, 2026 | 396.88M |
| August 18, 2026 | 396.88M |
| August 17, 2026 | 389.38M |
| August 14, 2026 | 378.99M |
| August 13, 2026 | 360.53M |
| August 12, 2026 | 338.60M |
| August 11, 2026 | 350.72M |
| August 10, 2026 | 353.61M |
| August 07, 2026 | 361.11M |
| August 06, 2026 | 353.61M |
| August 05, 2026 | 355.91M |
| August 04, 2026 | 365.14M |
| August 03, 2026 | 358.80M |
| July 31, 2026 | 353.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioLineRx Ltd. | 7.392M |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | -4.811M |
| Eocene Ltd. | -7.716M |
| Revium Recovery, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.262M |
| Revenue (Quarterly) | 54.92M |
| Total Expenses (Quarterly) | 45.66M |
| EPS Diluted (Quarterly) | 0.1605 |
| Gross Profit Margin (Quarterly) | 40.91% |
| Profit Margin (Quarterly) | 16.86% |
| Earnings Yield | 4.72% |
| Operating Earnings Yield | 5.86% |
| Normalized Earnings Yield | 4.846 |